The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
The Therapeutic Goods Administration (TGA) conducts an annual stakeholder survey to help report on our key performance indicators and make ongoing improvements to the way we work with our stakeholders. The 2020 survey covered topics from previous surveys while incorporating new questions in selected areas, such as advertising and medicine shortages.
The 2020 survey found that around 1 in 2 Australian consumers had heard of the TGA. Of those who were familiar with the TGA, the majority of consumer, health professional and medical products industry respondents trusted the TGA to act ethically and with integrity. The majority also believed that the TGA gets the balance right between access to therapeutic goods and safety for consumers.
Respondents were satisfied with their interactions with TGA staff and systems, although they highlighted various areas for improvement, including the user experience on our website. In a year marked by the pandemic, the majority of medical products industry respondents agreed that the TGA had responded effectively to COVID-19, though consumers in particular appeared to be uncertain or unaware of what our response entailed.
Overall, the 2020 survey results highlight an opportunity to build awareness of the TGA and our role in the Australian community.
We aim to provide documents in an accessible format. If you're having problems using this document, please contact TGA Education.
Contents
The TGA stakeholder survey report is structured to include a narrative overview of results at the beginning of the report (22 pages) followed by results tables for different stakeholder groups.
- Summary
- How to read this report
- The survey approach
- Overview of results
- Panel consumer results
- Panel pharmacist results
- Opt-in medical products industry results
- Opt-in consumer results
- Opt-in health professional results
- Appendix 1: Abbreviations